24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
ALS
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:55
Israel's NSO Group liable for hacking WhatsApp, says US judge
15:54
Unidentified drones: A challenge for the world, an opportunity for Israel
14:33
Amazon-backed robotics startup BionicHIVE shuts down with $18M debt
13:05
Full list of Israeli startup M&As in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli fintech Morning acquired for $150 million by Italy's TeamSystem
2
EU approves Nvidia’s $700M acquisition of Israeli startup Run:ai
3
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
4
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news
ALS
5 stories about ALS
NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI
28.07.22
|
CTech
The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it
Mind over Matter: The man who turned himself into a cyborg to overcome ALS
13.09.20
|
Yoghev Carmel
After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human
ALS Drug Developer NeuroSense Crowdfunds $1.15 Million
05.08.19
|
Adi Pick
The company’s 1,114 new investors will jointly own a 10% stake, the company said
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member
05.02.18
|
Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases
Please ensure Javascript is enabled for purposes of
website accessibility